Rubicon Research Limited.

Rubicon Research is an IP led CDMO and specialty pharmaceutical company that leverages proprietary drug delivery technologies, specialized formulation development skills, and project delivery experience to serve patients worldwide.
Our portfolio spans pharmaceutical product development and manufacturing across multiple dosage forms, including oral solids, oral liquids, sterile injectables, and drug-device combinations. We supply products to USA, EU, Australia, New Zealand, Canada, Turkey, and Korea, and are actively looking for partners in Emerging Markets.